3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Esophageal Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Ovarian Neoplasms
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Sunitinib
7
pembrolizumab
4
Nivolumab
4
cabozantinib
2
belzutifan
2
Ipilimumab
2
Everolimus
2
Axitinib
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
sacituzumab govitecan
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
lenvatinib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
entrectinib
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
avelumab
1
adavosertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Carcinoma, Renal Cell
×
Docetaxel
×
Clear all
No trials found.